Insider · CIK 0001724575

Flagship Ventures Fund V General Partner LLC

Reports to the SEC for 9 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001724575

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-08-11	Sigilon Therapeutics, Inc.U Disposition from Tender	10% Owner	UDisposition from Tender	−684K sh	$14.92	−$10.2M	0
2023-08-11	Sigilon Therapeutics, Inc.U Disposition from Tender	10% Owner	UDisposition from Tender	−114K sh	$14.92	−$1.7M	0
2023-06-07	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−177K sh	$6.24	−$1.11M	10,743,293
2023-06-07	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−22.8K sh	$6.24	−$142K	1,380,277
2023-06-06	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−181K sh	$6.31	−$1.14M	10,920,533
2023-06-06	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−22.3K sh	$6.31	−$141K	1,403,037
2023-05-26	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−72.7K sh	$6.23	−$452K	11,101,994
2023-05-26	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−9,330 sh	$6.23	−$58.1K	1,425,334
2023-05-25	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−102K sh	$6.35	−$649K	11,174,664
2023-05-25	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−13.1K sh	$6.35	−$83.4K	1,434,664
2023-05-24	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−308K sh	$6.57	−$2.02M	11,276,909
2023-05-24	SANASana Biotechnology, Inc.S Sale	10% Owner	SSale	−39.6K sh	$6.57	−$260K	1,447,791
2022-09-15	Codiak BioSciences, Inc.P Purchase	10% Owner	PPurchase	+723K sh	—	—	1,865,767
2022-09-15	Codiak BioSciences, Inc.P Purchase	10% Owner	PPurchase	+211K sh	—	—	1,188,920
2022-09-15	Codiak BioSciences, Inc.Warrants to purchase Common StockP Purchase	10% Owner	PPurchase	+723K sh	—	—	722,590
2022-09-15	Codiak BioSciences, Inc.Warrants to purchase Common StockP Purchase	10% Owner	PPurchase	+211K sh	—	—	210,743
2021-02-08	SANASana Biotechnology, Inc.C Conversion	10% Owner	CConversion	+1.49M sh	—	—	1,487,371
2021-02-08	SANASana Biotechnology, Inc.C Conversion	10% Owner	CConversion	+9.73M sh	—	—	9,725,122
2021-02-08	SANASana Biotechnology, Inc.C Conversion	10% Owner	CConversion	+11.4M sh	—	—	11,441,326
2021-02-08	SANASana Biotechnology, Inc.C Conversion	10% Owner	CConversion	+11.6M sh	—	—	11,585,199
2021-02-08	SANASana Biotechnology, Inc. · Series A-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.49M sh	—	—	0
2021-02-08	SANASana Biotechnology, Inc. · Series A-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−9.73M sh	—	—	0
2021-02-08	SANASana Biotechnology, Inc. · Series A-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−11.4M sh	—	—	0
2021-02-08	SANASana Biotechnology, Inc. · Series A-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−11.6M sh	—	—	0
2020-12-08	Sigilon Therapeutics, Inc.C Conversion	10% Owner	CConversion	+8.89M sh	—	—	8,888,888
2020-12-08	Sigilon Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.48M sh	—	—	1,481,481
2020-12-08	Sigilon Therapeutics, Inc.Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−4.44M sh	—	—	0
2020-12-08	Sigilon Therapeutics, Inc.Series A-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−4.07M sh	—	—	0
2020-12-08	Sigilon Therapeutics, Inc.Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−370K sh	—	—	0
2020-12-08	Sigilon Therapeutics, Inc.Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.48M sh	—	—	0
2020-10-27	FHTXFoghorn Therapeutics Inc.C Conversion	Director, 10% Owner	CConversion	+4.05M sh	—	—	4,054,054
2020-10-27	FHTXFoghorn Therapeutics Inc.C Conversion	Director, 10% Owner	CConversion	+4.5M sh	—	—	8,558,558
2020-10-27	FHTXFoghorn Therapeutics Inc.C Conversion	Director, 10% Owner	CConversion	+722K sh	—	—	9,280,878
2020-10-27	FHTXFoghorn Therapeutics Inc.P Purchase	Director, 10% Owner	PPurchase	+50K sh	$16.00	+$800K	9,330,878
2020-10-27	FHTXFoghorn Therapeutics Inc.C Conversion	Director, 10% Owner	CConversion	+1.44M sh	—	—	1,441,441
2020-10-27	FHTXFoghorn Therapeutics Inc.P Purchase	Director, 10% Owner	PPurchase	+50K sh	$16.00	+$800K	1,491,441
2020-10-27	FHTXFoghorn Therapeutics Inc.C Conversion	Director, 10% Owner	CConversion	+1.8M sh	—	—	1,801,801
2020-10-27	FHTXFoghorn Therapeutics Inc.P Purchase	Director, 10% Owner	PPurchase	+50K sh	$16.00	+$800K	1,851,801
2020-10-27	FHTXFoghorn Therapeutics Inc. · Series A-1 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−7.5M sh	—	—	0
2020-10-27	FHTXFoghorn Therapeutics Inc. · Series A-2 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−8.33M sh	—	—	0
2020-10-27	FHTXFoghorn Therapeutics Inc. · Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.34M sh	—	—	0
2020-10-27	FHTXFoghorn Therapeutics Inc. · Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.67M sh	—	—	0
2020-10-27	FHTXFoghorn Therapeutics Inc. · Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.33M sh	—	—	0
2020-10-16	Codiak BioSciences, Inc.C Conversion	10% Owner	CConversion	+544K sh	—	—	543,686
2020-10-16	Codiak BioSciences, Inc.C Conversion	10% Owner	CConversion	+544K sh	—	—	543,686
2020-10-16	Codiak BioSciences, Inc.C Conversion	10% Owner	CConversion	+339K sh	—	—	882,316
2020-10-16	Codiak BioSciences, Inc.C Conversion	10% Owner	CConversion	+339K sh	—	—	882,316
2020-10-16	Codiak BioSciences, Inc.C Conversion	10% Owner	CConversion	+95.9K sh	—	—	978,177
2020-10-16	Codiak BioSciences, Inc.C Conversion	10% Owner	CConversion	+95.9K sh	—	—	978,177
2020-10-16	Codiak BioSciences, Inc.P Purchase	10% Owner	PPurchase	+165K sh	$15.00	+$2.48M	1,143,177

Recent filings

Accepted (ET)
Aug 154
AFEYAN NOUBAR0000899243-23-018154
SEC(opens sec.gov)
Jun 84
AFEYAN NOUBAR0000899243-23-014953
SEC(opens sec.gov)
May 264
AFEYAN NOUBAR0000899243-23-013992
SEC(opens sec.gov)
Sep 164
AFEYAN NOUBAR0000899243-22-031404
SEC(opens sec.gov)
Feb 104
Flagship Ventures Fund V General Partner LLC0000899243-21-005747
SEC(opens sec.gov)

Companies

Address

55 CAMBRIDGE PARKWAY, SUITE 800E

CAMBRIDGE, MA, 02142